Clinical Trial Update: Anti-suicidal Effects of Buprenorphine in Opioid Use Disorder [Phase 4]

View source ↗

Summary

Phase 4 trial investigating anti-suicidal effects of buprenorphine in opioid use disorder was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder
• Suicidal Ideation

Drugs mentioned

• buprenorphine (buprenorphine)

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Opioid-use Disorder, Suicidal Ideation | Phase 4 | Status: WITHDRAWN